AnPac Bio-Medical Science Co., Ltd.
ANPC · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -93.2% | 97% | 64.9% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -7.6% | 78% | 70.6% | 55.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -7,474.1% | -338.7% | -452.4% | -757.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -7,394.3% | -315.9% | -1,045.1% | -757.1% |
| EPS Diluted | -16.9 | -13.95 | -39.2 | -17.22 |
| % Growth | -21.1% | 64.4% | -127.6% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |